CompaniesSagent Pharmaceuticals

Sagent Pharmaceuticals

active

Schaumburg, IL, United States

Founded 2006

About

Injectable Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalGeneric DrugMidwest

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

4,044

By Phase

PHASE2/PHASE3: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT04518410Collaborator

ACTIV-2: A Study for Outpatients With COVID-19

PHASE2/PHASE3Completed

4,044 participants

Started: Aug 19, 2020 · Completed: Jun 20, 2023

Funding History (20)

8-K

Aug 29, 2016

8-K

Jul 11, 2016

8-K

Jun 22, 2016

8-K

Jun 16, 2016

8-K

Jun 10, 2016

8-K

May 13, 2016

8-K

May 3, 2016

DEF 14A

Apr 29, 2016

8-K

Apr 6, 2016

8-K

Mar 28, 2016

Locations (1)

Headquarters

Schaumburg, IL, United States

Map

Loading map...